Your session is about to expire
← Back to Search
Interbody Device
DEXA-C Device for Degenerative Disc Disease (DEXA-C Trial)
N/A
Recruiting
Research Sponsored by Aurora Spine and Pain
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
DEXA-C Trial Summary
This trial tested a new medical device to help bones heal together faster in the neck.
Who is the study for?
This trial is for adults with degenerative disc disease who need cervical spine surgery (anterior cervical discectomy and fusion) at levels C3-7. They should have arm symptoms like pain or weakness due to nerve issues, confirmed by imaging tests, and must have tried non-surgical treatments for at least 6 weeks. People can't join if they've had recent neck surgery, severe spine joint wear-and-tear, need different types of neck surgeries, or belong to vulnerable groups unable to consent.Check my eligibility
What is being tested?
The DEXA-C Anterior Cervical Interbody System is being tested in this study. It's a device cleared by the FDA that's used during spinal fusion surgery in the neck area (cervical spine). The system is designed based on patients' bone density scans (DEXA) aiming to improve the rate at which bones grow together after surgery.See study design
What are the potential side effects?
While specific side effects are not listed here, typical risks associated with anterior cervical discectomy and fusion may include infection, bleeding, pain at the graft site, nerve damage leading to weakness or numbness, problems with voice or swallowing due to laryngeal nerve irritation.
DEXA-C Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Fusion Assesment
Secondary outcome measures
Subsidence
DEXA-C Trial Design
1Treatment groups
Experimental Treatment
Group I: Single Arm ObservationalExperimental Treatment1 Intervention
Cervical Interbody Cage
Find a Location
Who is running the clinical trial?
Aurora Spine and PainLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with degenerative disc disease in my neck.I had cervical spine surgery less than a year ago.I am scheduled for a specific spine surgery using the Dexa-C system and bone graft.I have tried physical therapy or pain medication for at least 6 weeks.I need surgery for nerve pain in my neck due to a problem with one or two specific neck bones.I have been diagnosed with severe spondylosis.I need surgery on the back or front of my neck, or a repeat neck surgery.I experience pain, numbness, or weakness in one or both arms.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment still open for this experiment?
"Correct. Clinicaltrials.gov reports that the trial, which was first published on February 22nd 2023 is still actively recruiting participants with its most recent update dated May 30th 2023."
Answered by AI
How many participants are allowed to join this clinical trial?
"Affirmative. Information available on clinicaltrials.gov confirms that this medical trial has been actively recruiting since February 22nd of 2023 and is still searching for 80 participants at two different sites, the most recent update having occurred on May 30th 2023."
Answered by AI
Who else is applying?
What state do they live in?
California
Nevada
What site did they apply to?
UCI Center for Clinical Research
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2
Recent research and studies
Share this study with friends
Copy Link
Messenger